Literature DB >> 17176982

Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome.

Leonard R Henry1, Elin Sigurdson, Eric A Ross, John S Lee, James C Watson, Jonathan D Cheng, Gary M Freedman, Andre Konski, John P Hoffman.   

Abstract

BACKGROUND: Recurrence in the pelvis after resection of a rectal or rectosigmoid cancer presents a dilemma. Resection offers the only reasonable probability for cure, but at the cost of marked perioperative morbidity and potential mortality. Clinical decision making remains difficult.
METHODS: Patients who underwent resection with curative intent for isolated pelvic recurrences after curative colorectal surgery from 1988 through 2003 were reviewed retrospectively. Clinical and pathological factors, salvage operations, and complications were recorded. The primary measured outcome was overall survival. Univariate and multivariate analyses were conducted to identify prognostic factors of improved outcome.
RESULTS: Ninety patients underwent an attempt at curative resection of a pelvic recurrence; median follow-up was 31 months. Complications occurred in 53% of patients. Operative mortality occurred in 4 (4.4%) of 90 patients. Median overall survival was 38 months, and estimated 5-year survival was 40%. A total of 51 of 86 patients had known recurrences (15 local, 16 distant, 20 both). Multivariate analysis revealed that preoperative carcinoembryonic antigen level and final margin status were statistically significant predictors of outcome.
CONCLUSIONS: The resection of pelvic recurrences after colorectal surgery for cancer can be performed with low mortality and good long-term outcome; however, morbidity from such procedures is high. Low preoperative carcinoembryonic antigen and negative margin of resection predict improved survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176982     DOI: 10.1245/s10434-006-9266-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

Review 1.  [Therapy of locally recurrent rectal carcinoma].

Authors:  H G Hempen; H R Raab
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

2.  ACR Appropriateness Criteria®-Recurrent Rectal Cancer.

Authors:  Andre A Konski; W Warren Suh; Joseph M Herman; A William Blackstock; Theodore S Hong; Matthew M Poggi; Miguel Rodriguez-Bigas; William Small; Charles R Thomas; Jennifer Zook
Journal:  Gastrointest Cancer Res       Date:  2012-01

Review 3.  Rectal cancer: a review.

Authors:  Mohammad Sadegh Fazeli; Mohammad Reza Keramati
Journal:  Med J Islam Repub Iran       Date:  2015-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.